Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Elevai Labs Inc. Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line June 28, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024 June 26, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs June 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm May 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference May 22, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Inc. Reports First Quarter 2024 Financial Results May 15, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity May 02, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments May 01, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments April 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months April 22, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results March 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market March 18, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office January 24, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach January 17, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology January 16, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB INMB ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences January 02, 2024 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023 December 11, 2023 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB ELEVAI Labs, Inc. Expands International Distribution into Europe December 07, 2023 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products November 29, 2023 From Elevai Labs Inc. Via GlobeNewswire Tickers ELAB Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.